Glucagon (swine),11-[N6-(1-oxodecyl)-L-lysine]- (9CI) (83512-38-3)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Glucagon (swine),11-[N6-(1-oxohexyl)-L-lysine]- (9CI)
- Glucagon (swine),12-[N6-(1-iminoethyl)-L-lysine]- (9CI)
- Glucagon (swine),N-acetyl-12-(N6-acetyl-L-lysine)- (9CI)
- Glucagon (swine),12-[N6-(aminoiminomethyl)-L-lysine]- (9CI)
- Glucagon (swine),1-L-alanine-12-[N6-(1-iminoethyl)-L-lysine]- (9CI)
- Glucagon (swine),1-L-phenylalanine-12-[N6-(1-iminoethyl)-L-lysine]- (9CI)
- Glucagon (swine),N-(2,4,6-trinitrophenyl)-12-[N6-(aminoiminomethyl)-L-lysine]- (9CI)
- L-Lysine,N6-(1-oxodecyl)-
- Glucagon (swine),N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-12-[N6-(1-iminoethyl)-L-lysine]-,monohydrochloride, [3aS-(3aa,4b,6aa)]- (9CI)
- Glucagon (swine),1-de-L-histidine-22-L-tyrosine- (9CI)
- 1-21-Glucagon (swine)(9CI)
- N2,N2-dimethyl-N6-(1-oxodecyl)-L-lysine
- Charybdotoxin(reduced), 11-(N6-acetyl-L-lysine)- (9CI)
- Glucagon (swine),25-[1-[(4-azido-2-nitrophenyl)thio]-L-tryptophan]- (9CI)
- L-Lysine,N2-(1-oxodecyl)-
- Glucagon (swine),25-(2-mercapto-L-tryptophan)- (9CI)
- Glucagon (swine),27-[4-(methylsulfinyl)-L-2-aminobutanoic acid]- (9CI)
- Neuropeptide Y (swine),7-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
- Glucagon (swine),N-(aminocarbonyl)- (9CI)
- Glucagon-like peptideII (swine) (9CI)
